• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETNHX:US

17.09 USD 0.10 0.58%

As of 09:29:30 ET on 10/22/2014.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETNHX)

Year To Date: +5.17% 3-Month: +7.69% 3-Year: - 52-Week Range: 14.14 - 19.91
1-Month: +3.08% 1-Year: +14.45% 5-Year: - Beta vs SPX: 1.02

Mutual Fund Chart for ETNHX

No chart data available.
  • ETNHX:US 17.09
  • 1M
  • 1Y
Interactive ETNHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETNHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETNHX

NAV (on 2014-10-22) 17.09
Assets (M) (on 2014-10-22) 111.94
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for ETNHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETNHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.20
Expense Ratio 1.63

Top Fund Holdings for ETNHX

Filing Date: 06/30/2014
Name Position Value % of Total
Fidelity Institutional Money M 11,947,504 11,947,504 10.105%
Agios Pharmaceuticals Inc 94,600 4,334,572 3.666%
Medivation Inc 41,500 3,198,820 2.706%
Bluebird Bio Inc 76,900 2,966,033 2.509%
Dyax Corp 303,000 2,908,800 2.460%
AtriCure Inc 152,300 2,799,274 2.368%
Salix Pharmaceuticals Ltd 21,800 2,689,030 2.274%
GW Pharmaceuticals PLC 25,000 2,682,250 2.269%
AbbVie Inc 47,000 2,652,680 2.244%
Veracyte Inc 154,700 2,648,464 2.240%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil